$76,105,626

Establishes a coordinating center to evaluate and assess health technologies through a national evaluation system.

Strengthens FDA's capacity to systematically evaluate medical device safety and effectiveness, improving regulatory decision-making and market access.

Signals increased FDA scrutiny and standardized evaluation pathways for medical device manufacturers and health technology developers.

Enhances U.S. regulatory rigor for medical devices, potentially creating barriers to lower-cost foreign device imports while supporting domestic innovation.